Filing Details

Accession Number:
0001683168-23-006169
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-30 15:15:59
Reporting Period:
2023-08-25
Accepted Time:
2023-08-30 15:15:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759186 Coeptis Therapeutics Holdings Inc. COEP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1592481 Gene Salkind 105 Bradford Road, Suite 420
Wexford PA 15090
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-25 28,638 $0.91 28,638 No 4 P Indirect By Trust
Common Stock Acquisiton 2023-08-29 4,006 $1.01 4,046 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
No 4 P Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 250,046 Direct
Footnotes
  1. The Marital Trust GST Subject U/W/O Leopold Salkind, for which the Reporting Person is the trustee.
  2. Includes (i) 84,217 shares of common stock that are held as JTWROS with Catherine Salkind, (ii) 57,268 shares of commonstock issuable upon exercise of currently exercisable warrants held as JTWROS with Catherine Salkind, (iii) 101,061 shares ofcommon stock that are issuable upon currently exercisable warrants and (iv) 7,500 shares of common stock that are issuable uponexercise of options that will become exercisable in the next 60 days. Does not include 22,500 shares of common stock that areissuable upon exercise of options that are not currently exercisable and will not become exercisable in the next 60 days.
  3. Julian R Salkind Trust DTD 10/11/94, for which the Reporting Person is the Trustee.